Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 3, 2017

View Archived Issues

Regen Biopharma enters agreement to optimize NR2F6 modulators

Hope Biosciences gains rights to MERTK/AXL inhibitor from NeoPharm

Biogen completes separation of global hemophilia business and launches Bioverativ

FDA orphan drug status given to CyTIX-DCf 12-GLI for malignant glioma

Increased potency of CB-2679d may allow subcutaneous dosing for hemophilia B

FDA grants accelerated approval to Opdivo in metastatic urothelial carcinoma

FDA grants authorization for Abbott RealTime ZIKA test to detect Zika virus using whole blood

Vividion Therapeutics launches with novel drug discovery platform

Protagen and NCI collaborate to provide insight into immuno-oncology

Repatha cardiovascular outcomes study and cognition function study meet primary endpoints

Summit Therapeutics outlines phase III program for ridinilazole

Fortress Biotech's Mustang Bio closes private placement financing to support immunotherapy pipeline

Sustained factor IX activity seen with single infusion of SPK-9001 gene therapy

Galapagos begins dosing patients with cystic fibrosis in ALBATROSS study

GenomeDx to perform genomic tumor profiling for Astellas' ENACT study of enzalutamide

Aviragen reports topline data from phase IIa study of BTA-585 for RSV

Soligenix's SGX-301 granted PIM designation in U.K.

FDA gives orphan drug designation to Lysogene's gene therapy candidate for GM1 gangliosidosis

Glecaprevir/pibrentasvir NDA granted priority review by FDA

Guangzhou Maxinovel Pharmaceuticals divulges novel tyrosine kinase inhibitors

Sunshine Lake Pharma patents orexin receptor antagonists

Bayer discloses new mutant IDH1 inhibitors

Ono Pharmaceutical discovers prostanoid EP2 receptor agonists

Astellas Pharma offers overview of third quarter of fiscal 2016

Pharmakea presents novel lysyl oxidase homolog 2 inhibitors

Daiichi Sankyo reports key milestones of third quarter of fiscal 2016

Promising MOD-5014 results in a phase I/IIa clinical trial in hemophilia patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...